当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

"酶免"产品文献：Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

酶免官方商城 / 2023-08-25

文献标题

Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

文献作者

Yingying Shi、Yu Liu、Jiaxin Huang、Zhenyu Luo、Xuemeng Guo、Mengshi Jiang、Xiang Li、Yichao Lu、Xu Liu、Xinyu Shan、Lihua Luo、Jian You

发表时间

2022年04月24日

文献影响因子

11.556

使用的酶免科研试剂盒产品名称

小鼠白细胞介素12（IL-12/P70）ELISA科研试剂盒

下一篇:"酶免"产品文献：Transcriptome analysis of healthy and fatty liver revealed that inhibition of SLCO1B3 induces abnormal liver metabolism and lipid synthesis
上一篇:"酶免"产品文献：Dioscin potentiates the antitumor effect of suicide gene therapy in melanoma by gap junction intercellular communication-mediated antigen cross-presentation

全部产品分类

浏览历史

"酶免"产品文献：Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy